| Welcome & Situation updates Chair: Charles McGurk, Chairman of TriNation |
| WelcomeCharles McGurk, Skretting AS |
| Update on PD in Ireland Hamish Rodger, VetAqua International |
| Geographical distribution of SAV subtypes in Scotland and Ireland Marian McLoughlin, Aquatic Veterinary Services |
| Status of PD and HSMI in ChileElena Orellana, Sernapesca |
| PD in Norway Britt Bang Jensen, Norwegian Veterinary Institute |
| SAV2-epidemic in NorwayMonika Hjortaas, Norwegian Veterinary Institute |
| New and ongoing research projectsChair: Merete Bjørgan Schrøder, FHF |
| Bibliography of new publications last 5 yrsMarian McLoughlin, Aquatic Veterinary Services |
| Presentation of three new research projects on CMS in NorwaySven Martin Jørgensen, Nofima |
| FishPathogens.eu –a common tool to organize aquatic viruses Helle Frank Skall, Technical University of Denmark |
| Presentation of a new project on SAV2 in Norwegian aquacultureHilde Sindre, Norwegian veterinary Institute |
| EpidemiologyChair: Britt Bang Jensen, Norwegian Veterinary Institute |
| Risk map and spatial determinants of PD in Norwegian salmon farming sitesSaraya Tavornparnich, Norwegian veterinary Institute |
| Seasonal temperature change influence the dynamic of PD in salmon aquacultureAnne Stene, Aalesund University College |
| Prevalence of SAV in common dab in Scottish watersDavid Bruno |
| Genome characterization of flatfish alphavirus and its risk to aquacultureIveta Matejusova |
| Pathology and pathogenicityChair: Randolph Richards, University of Stirling |
| The Effect of Dietary Lipids on the Pathology of Salmon Pancreas DiseaseTharangani Herath, University of Stirling |
| Comparative pathogenicity of Norwegian Sav2 and SAV3 in experimental challengePetter Frost, Intervet Norbio |
| Increased protective immune responses in a whole-virus Ag vaccine against SAVHanna L Thim, University of Tromsø |
| Clinical aspects of SAV 2 induced pancreas disease in Shetland Marian McLoughlin, Aquatic Veterinary Services / David Sutherland, Westside vets |
| Vaccination and control Chair: Michael Welsh, AFBI |
| Comparison of different vaccines and vaccine booster regimes against PDStephen Mutoloki, Norwegian School of Veterinary Science |
| Efficacy of an inactivated whole-virus vaccine against SAV in laboratory challengesMarius Karlsen, Pharmaq AS |
| Vaccines against SPDV – results from a large scale GCP field trial conducted in Norway 2010-2012Terje Tingbø, Pharmaq AS |
| Field Experience of Norvax Compact PD use in the UKDafydd Morris, MSD Animal Health UK |
| Field Experience of Norvax Compact PD use in NorwayDag Knappskog, MSD Animal Health |
| Innate responses to salmonid alphavirus infectionsØystein Evensen, Norwegian School of Veterinary Science |
| Efficacy and Safety Studies of a SAV NAV Vaccine in salmonVolker Gorenflo, Novartis |
| Evaluation of the PD-control strategy in NorwayBrit Hjeltnes, Norwegian Veterinary Institute |
| Recurrent infections with PDTorunn Taksdal, Norwegian Veterinary Institute |
| Diagnostics and methodologyChair: Paul Midtlyng, Novartis |
| Novel biomarker discovery through analysis of the serum proteome of Atlantic salmon during pancreas disease John Tinsley, Biomar AS |
| Development of alternative methods for the in vitro study of heart affecting diseases and host- pathogen interactionsPatricia Noguera |
| Workshops |
| Review of the diagnostic criteria and the role of concurrent infection with PD, HSMI and CMSChair: Kim Thompson, University of Stirling |
| Identification of knowledge gapsChair: Gordon Ritchie, Marine Harvest |
